Edarbi Tablet
Product Images NDC 60631-040

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Edarbi (NDC 60631-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Edarbi 01)

Chemical structure of Azilsartan kamedoxomil, the active ingredient in Edarbi tablets. The diagram shows the molecular arrangement including rings and functional groups with a potassium ion (K+).*

FDA Label Image

Figure 1 (Edarbi 02)

A pharmacokinetic (PK) chart showing fold change and 90% confidence intervals for Edarbi (azilsartan kamedoxomil) comparing various population groups including age, gender, race, renal and hepatic impairment, against a reference. It presents Cmax and AUC data with corresponding dose adjustment recommendations, mostly indicating no dose adjustment needed except for groups labeled as 'No Experience.'*

FDA Label Image

Figure 2 (Edarbi 03)

Two line graphs comparing the effects of Edarbi 80 mg, Olmesartan 40 mg, Valsartan 320 mg, and placebo on systolic and diastolic blood pressure over a 24-hour postdose period. The top graph shows systolic blood pressure (mm Hg) over time, while the bottom graph displays diastolic blood pressure (mm Hg) over the same timeline, illustrating the blood pressure changes for each treatment and placebo.*

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Edarbi 40 mg oral tablets label showing the brand name with generic name Azilsartan medoxomil, strength of 40 mg per tablet, and packaging for 30 tablets. Label includes storage instructions, dosage note to see package insert, manufacturer information for Arbor Pharmaceuticals and Takeda Ireland, and barcode with GTIN and lot information.*

FDA Label Image

Principal Display Panel (80 mg Tablet Bottle Label)

Edarbi 80 mg tablets label showing the product name and generic name azilsartan medoxomil. The label includes dosage strength, storage instructions, manufacturer information for Arbor Pharmaceuticals, LLC, and manufacturing site in Ireland by Takeda. The label also displays the barcode, NDC number 60631-080-30, and a QR code with additional batch details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.